The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
Researchers summarize the multitude of ways access to and utilization of treatment for individuals with OUD might have been expanded by state and federal policy during COVID-19 pandemic in 4 key areas: telehealth, privacy, licensing, and medication.
The cover story highlights how RAND is helping to redefine high-quality care for service members with a TBI or PTSD. The Q&A with two Marines who work at RAND sheds light on how their military service informs their research and analysis.
Army recruits with a history of marijuana use can ask for a waiver like those who have diabetes or insomnia. They are just as likely as others to complete their first term and make sergeant, and are less likely to leave the Army for health or performance reasons.
Some communities hard hit by the opioid crisis are interested in opening supervised consumption sites—places where people who use drugs can do so under supervision of trained staff. What could be done to make it easier to pilot and evaluate these sites in the United States?
This cross-sectional study of substance use disorder treatment facilities examined the national share of facilities that offer medication treatment for opioid use disorder (MOUD) and population-based measures of geographic accessibility of facilities offering MOUD.
This study used a decade of data from U.S. counties to examine how rates of neonatal opioid withdrawal syndrome (NOWS) and county-level characteristics were associated with entry in the child welfare system.
We reviewed medical literature for recent studies that use claims data to construct opioid utilization measures, then developed a guide for researchers regarding opioid utilization measures and measure definitions, and how these may influence study results.
Fentanyl and other synthetic opioids are displacing heroin in some major drug markets. What might happen to Afghanistan—the world's largest producer of illegal opium poppy—if demand for its opiates dropped off sharply and permanently?
This study examined receipt of services for mental health conditions and non-opioid substance use disorders among privately insured adolescents and young adults (ie, youth) with subsequent clinically diagnosed opioid use disorder or opioid poisoning.
RAND researchers provide a toolkit to support the delivery of effective, evidence-based pharmacotherapy for clients with co-occurring substance use and mental health disorders and simplify care implementation in mental health clinics.